1. Home
  2. UTF vs HAE Comparison

UTF vs HAE Comparison

Compare UTF & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers Infrastructure Fund Inc

UTF

Cohen & Steers Infrastructure Fund Inc

HOLD

Current Price

$26.98

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$54.98

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTF
HAE
Founded
N/A
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.8B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
UTF
HAE
Price
$26.98
$54.98
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$84.13
AVG Volume (30 Days)
295.3K
631.0K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.54
EPS
N/A
2.46
Revenue
N/A
$910,373,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.23
P/E Ratio
N/A
$22.17
Revenue Growth
N/A
N/A
52 Week Low
$23.42
$47.32
52 Week High
$27.35
$87.32

Technical Indicators

Market Signals
Indicator
UTF
HAE
Relative Strength Index (RSI) 60.91 42.10
Support Level $26.65 $54.92
Resistance Level $27.17 $56.64
Average True Range (ATR) 0.34 2.73
MACD 0.04 -0.60
Stochastic Oscillator 74.07 41.01

Price Performance

Historical Comparison
UTF
HAE

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. Under normal market conditions, the fund invests the majority of its managed assets in securities issued by infrastructure companies, which consist of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: